New preclinical obesity drug combines five mechanisms in mice; NIH funding crisis; Novartis reshoring; Alzheimer's program halted; other pharma news.
FDA moves to exclude semaglutide and tirzepatide from bulk compounding list, impacting access to cheaper weight loss drugs.
Trump replaces Casey Means with Nicole Saphier for Surgeon General, mixing MAHA wellness with conventional medicine skepticism.
A new Science study shows AI beating doctors in diagnostic tests, but researchers warn against misusing simulated results as proof of safety for real patients. Cautious optimism is needed.
Explore biotech innovations in hair loss treatments, AI in clinical trials, and nonprofit M&A strategies, featuring insights from Veradermics and Servier.
Nicole Saphier, the new surgeon general nominee, brings medical credentials and a nuanced stance on vaccines and the MAHA movement, balancing enthusiasm for reform with evidence-based caution.
Katherine Szarama named acting director of FDA's CBER, replacing Vinay Prasad after his controversial tenure. CBER oversees vaccines, gene therapies, and blood supply.
J. Craig Venter, who transformed genetics from artisanal to industrial, died at 79. He raced to sequence the human genome, explored ocean microbes, and created synthetic life.
Purdue Pharma dissolves after federal judge approves criminal sentence, replacing it with a public-benefit company as part of a landmark opioid settlement. The decision follows emotional victim testimony and addresses over 900,000 opioid-related deaths since 1999.
The US fertility decline reflects economic pressures like childcare costs, housing unaffordability, healthcare gaps, and no paid leave, not just personal choices. Policy support needed.
Julia Vitarello, whose daughter received a bespoke genetic therapy, is launching a new biotech to scale individualized treatments for rare mutations.
FDA survey finds low levels of PFAS (forever chemicals) in half of infant formula samples, but most at less than 2.9 ppt, indicating overall safety while experts call for continued reduction efforts.
As psychedelic therapies gain traction, people of color face barriers in access and research. This article examines disparities and proposes equity measures.
PFAS 'forever chemicals' persist in some infant formulas despite regulatory efforts. This article explores sources, health risks for infants, and practical steps parents can take to reduce exposure.
Explores humility as a core value across professions, using a designer's journey through the early web to illustrate how embracing humility fosters growth, collaboration, and better outcomes.
User research follows a three-act storytelling structure: setup (foundational research), conflict (formative research), and resolution (summative research). Using this framework engages stakeholders and makes insights memorable.
Design systems should function as living languages, speaking dialects for different contexts. Rigid consistency fails; adaptation solves real problems, as shown by Booking.com and Shopify cases.
Explores why well-meaning designers create inaccessible sites and offers a solution based on Nielsen's heuristic of recognition over recall to embed accessibility naturally.
Explore Gemma 4's role in on-device AI, its NVIDIA-optimized variants, capabilities, performance, and how OpenClaw enables local agentic assistants.
At Hannover Messe 2026, NVIDIA and partners showcase AI-driven manufacturing with the Industrial AI Cloud, AI-accelerated engineering, and robotics, demonstrating the factory of the future in action.